מולקולות ctla4 מוטנטיות לשימוש בטיפול בתיסמונות חיסוניות הקשורות בהשתלת שתל
- 专利权人:
- BRISTOL-MYERS SQUIBB COMPANY
- 发明人:
- 申请号：
- IL18618907
- 公开号：
- IL186189A
- 申请日:
- 2007.09.23
- 申请国别(地区):
- IL
- 年份:
- 2015
- 代理人:
- 摘要：
- The present invention provides use of soluble CTLA4 mutant molecules which bind with greater avidity to the CD80 and/or CD86 antigen than wild type CTLA4 or non-mutated CTLA4Ig in the treatment of immune disorders associated with graft transplantation.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Metody leczenia zaburzeń immunologicznych związanych z transplantacją narządów rozpuszczalnymi zmutowanymi cząsteczkami CTLA4
- Postopki za zdravljenje imunskih motenj, povezanih s transplantacijo presadkov s topnimi mutiranimi CTLA4 molekulami
- Methods for Treating Immune Disorders Associated with Graft Transplantaton with Soluble CTLA4 Mutant Molecules
- METHODS OF TREATING IMMUNE DISEASES IN CONNECTION WITH ORGAN TRANSPLANTATION WITH SOLUBLE, Mutating CTLA4 MOLECULES
- Methods for treating immune disorders associated with graft transplantation with soluble CTLA4 mutant molecules
